We are live on ! Find out more
CSS

Cubist Systematic Strategies Portfolio holdings

AUM $21B
1-Year Est. Return 21.48%
This Fund
S&P 500
This Quarter Est. Return
-15.79%
1 Year Est. Return
+21.48%
3 Year Est. Return
+78.34%
5 Year Est. Return
+110.56%
10 Year Est. Return
+239.04%
AUM
$16.4B
AUM Growth
+$4.51B
Cap. Flow
+$7.45B
Cap. Flow %
45.53%
Top 10 Hldgs %
3.04%
Holding
4,763
New
1,229
Increased
1,758
Reduced
1,274
Closed
428

Top Buys

Rank Stock Value
1
AXP icon
American Express
AXP
+$71M
2
BAC icon
Bank of America
BAC
+$53.3M
3
MPC icon
Marathon Petroleum
MPC
+$49.5M
4
ILMN icon
Illumina
ILMN
+$47.8M
5
NKE icon
Nike
NKE
+$44.9M

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$43.1M
2
ZTS icon
Zoetis
ZTS
+$33.2M
3
CL icon
Colgate-Palmolive
CL
+$25.5M
4
QCOM icon
Qualcomm
QCOM
+$23.7M
5
FRC
First Republic Bank
FRC
+$23.1M

Sector Composition

Rank Sector Weight
1 Financials 15.38%
2 Technology 14.53%
3 Consumer Discretionary 10.24%
4 Healthcare 9.93%
5 Industrials 9.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
APLT
4301
DELISTED
Applied Therapeutics
APLT
$4K ﹤0.01%
4,038
– –
BDX icon
4302
Becton Dickinson
BDX
$48.2B
$4K ﹤0.01%
18
-12,512
-100% -$3.18M
KYNB
4303
Kyntra Bio
KYNB
$29.4M
$4K ﹤0.01%
13
-1,872
-99% -$478K
RIOT icon
4304
Riot Platforms
RIOT
$7.76B
$4K ﹤0.01%
905
-2,377
-72% -$22.1K
ROIV icon
4305
Roivant Sciences
ROIV
$26.2B
$4K ﹤0.01%
+998
New +$3.96K
BRDS
4306
DELISTED
Bird Global, Inc.
BRDS
$4K ﹤0.01%
409
-3,483
-89% -$106K
AVTX icon
4307
Avalo Therapeutics
AVTX
$983M
$3K ﹤0.01%
2
+1
+100% +$1.34K
CNTA
4308
DELISTED
Centessa Pharmaceuticals
CNTA
$3K ﹤0.01%
+568
New +$3.63K
FHTX icon
4309
Foghorn Therapeutics
FHTX
$360M
$3K ﹤0.01%
209
-8,944
-98% -$115K
NAT icon
4310
Nordic American Tanker
NAT
$1.37B
$3K ﹤0.01%
+1,458
New +$3.48K
NPCE icon
4311
Neuropace
NPCE
$506M
$3K ﹤0.01%
651
+633
+3,517% +$4.18K
SOS
4312
SOS Limited
SOS
$14.6M
$3K ﹤0.01%
+22
New +$6.38K
VIGL
4313
DELISTED
Vigil Neuroscience
VIGL
$3K ﹤0.01%
1,118
+118
+12% +$466
MYNA
4314
DELISTED
Mynaric AG American Depository Shares
MYNA
$3K ﹤0.01%
400
-700
-64% -$6.4K
PACX
4315
DELISTED
Pioneer Merger Corp. Class A Ordinary Share
PACX
$3K ﹤0.01%
+310
New +$3.05K
AMPE
4316
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$3K ﹤0.01%
+60
New +$4.47K
NBEV
4317
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$3K ﹤0.01%
+12,405
New +$4.68K
KRYS icon
4318
Krystal Biotech
KRYS
$9.66B
$2K ﹤0.01%
37
– –
SRDX
4319
DELISTED
Surmodics
SRDX
$2K ﹤0.01%
58
-172
-75% -$6.67K
VRCA icon
4320
Verrica Pharmaceuticals
VRCA
$87.3M
$2K ﹤0.01%
+120
New +$6.03K
ACHL
4321
DELISTED
Achilles Therapeutics
ACHL
$2K ﹤0.01%
685
+100
+17% +$247
SHCR
4322
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$2K ﹤0.01%
1,201
-163,349
-99% -$401K
NBSE
4323
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
$2K ﹤0.01%
92
-34
-27% -$798
IEA
4324
DELISTED
Infrastructure and Energy Alternatives, Inc. Common Stock
IEA
$2K ﹤0.01%
+200
New +$1.87K
CIFR icon
4325
Cipher Digital
CIFR
$7.13B
$1K ﹤0.01%
700
-92,378
-99% -$225K
171 172
173
174 175

Similar funds

GIM
Glenmede Investment Management Philadelphia, Pennsylvania $20.7B AUM
ECM
Eisler Capital Management London, United Kingdom $22.6B AUM 9.36% 1-Year Est. Return
JFL
Jarislowsky, Fraser Ltd Montreal, Quebec, Canada $18.2B AUM 22.04% 1-Year Est. Return
BAM
Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return
SF
Synovus Financial Columbus, Georgia $8.74B AUM 12.78% 1-Year Est. Return
WIM
Waverton Investment Management London, United Kingdom $7.77B AUM 25.07% 1-Year Est. Return
AIM
AXA Investment Managers Puteaux, France $37.1B AUM
SIG
Stonegate Investment Group Birmingham, Alabama $4.31B AUM 18.07% 1-Year Est. Return

Cubist Systematic Strategies's Q2 2022 Portfolio in Review

As of Q2 2022, Cubist Systematic Strategies held 4,763 positions worth $16.4B, up 38% from $11.8B the previous quarter. Its ten largest holdings account for 3% of the portfolio.

Cubist Systematic Strategies deployed $7.45B of net new capital in Q2 2022, opening 1,229 new positions and adding to 1,758 existing holdings. Its largest new stake was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, down from 18% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Verizon, an estimated $43.1M trimmed.

  • Cubist Systematic Strategies's largest Q2 2022 buy was Sierra Lake Acquisition Corp. Class A Common Stock: 1,393,075 shares worth $13.8M.
  • Cubist Systematic Strategies added most to American Express in Q2 2022, an estimated $71M increase.
  • Cubist Systematic Strategies's biggest Q2 2022 reduction was Verizon, cutting an estimated $43.1M.
  • Cubist Systematic Strategies fully exited UnitedHealth in Q2 2022, selling an estimated $17.1M.
  • Cubist Systematic Strategies's ten largest holdings make up 3% of its $16.4B portfolio in Q2 2022.
  • Cubist Systematic Strategies opened 1,229 new positions and closed 428 in Q2 2022.
  • Cubist Systematic Strategies's portfolio value rose 38% quarter-over-quarter to $16.4B.

Based on Cubist Systematic Strategies's 13F filing for Q2 2022, filed 15 Aug 2022.